Management of childhood arthritis. Part 2: Chronic arthritis

Archives of Disease in Childhood

Volumn 76, Issue 6, 1997, Pages 541-544

  Malleson, P N ^a,b  

^a Research Centre   (Canada)

^b Paediatric Rheumatology   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; FOLIC ACID; HYDROXYCHLOROQUINE; METHOTREXATE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; SALAZOSULFAPYRIDINE; TOLMETIN; TRIAMCINOLONE HEXACETONIDE;

CHILDHOOD DISEASE; CHRONIC ARTHRITIS; DRUG CHOICE; DRUG INDICATION; FUNCTIONAL ASSESSMENT; HUMAN; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION;

EID: 0030786481     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.76.6.541     Document Type: Review

References (40)

1. Brewer EJJ, Bass J, Baum J, et al. Current proposed revision of JRA criteria. Arthritis Rheum 1977;20(suppl): 195-9.
2. Wood P. Special meeting on nomenclature and classification of arthritis in children. The care of rheumatic children. Basle: EULAR, 1978:47-50.
3. Fink C\V. Task force for classification criteria. Proposal for the development of classification criteria for idiopathic arthritides of childhood. J Rhcumaiol 1995;22:1566-9.
4. Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 1949;140:659-62.
5. Howe S, Levinson J, Shear E, et al. Development of a disability measurement tool for juvenile rheumatoid arthritis. Arthritis Rheum 1991;34:873-80.
6. Lovell DJ, Howe S, Shear E, et al. Development of a disability measurement tool for juvenile rheumatoid arthritis. The juvenile arthritis functional assessment scale. Arthritis Rlieum 1989;32:1390-5.
7. Singh G, Athreya BH, Fries JF, Goldsmith DP. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum 1994;37:1761-9.
8. Wright FV, Kimber JL, Law M, Goldsmith CH, Crombie V, Dent P. The juvenile arthritis functional status index (JASI): a validation study. JRheumatol 1996;23:1066-79.
9. Duffy CM, Arsenault L, Duffy KN. Level of agreement between parents and children in rating dysfunction in juvenile rheumatoid arthritis and juvenile spondyloarthritides. J Rheumatol 1993;20:2134-9.
10. Tucker LB, Denardo BA, Schaller JG. The childhood arthritis health profile correlation of juvenile rheumatoid arthritis (JRA)-specific scales with disease severity and activity [abst]. Arthritis Rheum 1996;39:S56.
11. Alien RC, Gross KR, Laxer RM, Malleson PN, Beauchamp RD, Petty RE. Intraarticular triamcinolone hexacetonide in the management of chronic arthritis in children. Arthritis Rheum 1986;29:997-1001.
12. Huppertz H, Tschammler A, Horwitz AE, Schwab KO. Intraarticular corticosteroids for chronic arthritis in children: efficacy and effects on cartilage and growth. J Pediatr 1995;127:317-21.
13. Sparling M, Malleson P, Wood B, Petty R. Radiographic follow up of joints injected with triamcinolone hexacetonide for the management of childhood arthritis. Arthritis Rheum 1990;33:821-6.
14. Wilske KR, Healey LA. Remodeling the pyramid: a concept whose time has come. J Rheumatol 1989;16:565-7.
15. Fries JF. Reevaluating the therapeutic approach to rheumatoid arthritis: the 'sawtooth strategy'. J Rheumatol 1990; 17(suppl22):12-115.
16. Malleson PN, Petty RE. Remodelling the pyramid - a pediatric perspective. J Rheumatol 1990;17:867-8.
17. Levinson JE, Wallace CA. Dismantling the pyramid. J Rheumatol 1992;19(suppl 33):6-10.
18. Fries JF, Spitz PW, Williams CA, Bloch DA, Singh G, Hubert HB. A toxicity index for comparison of side effects among different drugs. Arthritis Rheum 1990;33:121-30.
19. Fries JF, Williams CA, Bloch DA. The relative toxicity of nonsteroidal antiinflammatory drugs. Arthritis Rlieum 1991:34:1353-60.
20. Fürst DE. Toxicity of anrirheumaric medications in children with juvenile arthritis. J Rheumatol 1992;19(suppl 33):11-5.
21. Giannini EH, Brewer EJ, Kuzmina N, et al. Methotrexate in resistant juvenile rheumatoid arthritis. Results of the USA-USSR double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and the Cooperative Children's Study Group. N Engl J Med 1992;326:1043-9.
22. Giannini EH, Cassidy JT, Brewer EJ, Shaikov A. Comparative efficacy and safety of advanced drug therapy in children with juvenile rheumatoid arthritis. Sentin Arthritis Rheum 1993;23:34-46.
23. Wallace CA, Sherry DD, Mellins ED, Aiken RP. Predicting remission in juvenile rheumatoid arthritis with methotrexate treatment. J Rheumatol 1993;20:118-22.
24. Kugathasan S, Newman AJ, Dahms BB, Boyle JT. Liver biopsy findings in patients with juvenile rheumatoid arthritis receiving long-term, weekly methotrexate therapy. J Pediatr 1996;128:149-51.
25. Dougados M, van der Linden S, Leirisalo-Repo M, et al. Sulfasalazine in the treatment of spondylarthropathy: a randomized, multicenter, double-blind, placebo-controlled study. Arthritis Rheum 1995;38:618-27.
26. Imundo LF, Jacobs JC. Treatment of juvenile arthritis (JA) with Sulfasalazine [abst]. Arthritis Rlieum 1993;36(suppl 9):S122.
27. Ravelli A, De Benedetti F, Viola S, Martini A. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine. J Pediatr 1996;12S:275-8.
28. Giannini MJ, Protas EJ. Aerobic capacity in juvenile rheumatoid arthritis patients and healthy children. Arthritis Care Res 1991;4:131-5.
29. Giannini MJ, Protas EJ. Exercise response in children with and without juvenile rheumatoid arthritis: a casecomparison study. Phys Ther 1992;72:365-72.
30. Malleson PN, Bennett SM, Mackinnon M, et al. Physical fitness and its relationship to other indices of health status in children with chronic arthritis. J Rheumatol 1996;23: 1059-65.
31. May J. Rebalancing the mobile; the impact of chronic illness/disability on the family. J Rheumatol 1992;19:2-5.
32. McCormick MC, Stemmler MM, Athreya BH. The impact of childhood rheumatic diseases on the family. Arthritis Rheum 1986;29:872-9.
33. Hill RH, Herstein A, Walters K. Juvenile rheumatoid arthritis: follow up into adulthood-medical, sexual and social status. Can MedAssocJ 1976;114:790-6.
34. Litt IF, Cuskey WR, Rosenberg BA. Role of self-esteem and autonomy in determining medication compliance among adolescents with juvenile rheumatoid arthritis. Pediatrics 1982;69:15-7.
35. Rettig P, Athreya BH. Adolescents with chronic disease. Transition to adult health care. Arthritis Care Res 1987;4:I74-80.
36. Berry SL, Hayford JR, Ross CK, Pachman LM, Lavigne JV. Conceptions of illness by children with juvenile rheumatoid arthritis: a cognitive developmental approach. J Pediatr Psychol 1993;18:83-97.
37. Southwood TR, Malleson PN, eds. Arthritis in children and adolescents. London: Bailliere Tindall, 1993.
38. Cassidy JT, Petty RE. Textbook of pediatric rheumatology. 3rd Ed. Philadelphia: Saunders, 1995.
39. Woo P, White PH, Ansell BM, eds. Pasdiatric rheumatology update. Oxford: Oxford University Press: 1990.
40. Wright V, ed. Pediatric rheumatic diseases. In: Melvin JL, ed. Rheumatologic rehabilitation. Bethesda: American Occupational Therapy Association, 1997.